Indian equity benchmarks closed higher on October 9, continuing their positive momentum. The BSE Sensex ended the day at 82,172.10, gaining 398.44 points (0.49%), while the NSE Nifty 50 settled at 25,181.80, up 135.65 points (0.54%).
Market watchers will be keenly tracking quarterly earnings updates, AI investment announcements, restructuring timelines, and major project awards that could trigger sector-specific movements and stock-specific activity in today’s trade.
Tata Motors, auto giant announced that its restructuring scheme involving TML Commercial Vehicles Ltd (TMLCV) and Tata Motors Passenger Vehicles Ltd (TMPV) became effective on October 1, 2025, following approval from the NCLT Mumbai Bench.
Under the scheme, Tata Motors’ commercial vehicle business has been demerged into TMLCV, while TMPV is being merged with Tata Motors. The company has set October 14, 2025, as the record date for shareholders to receive one TMLCV share (₹2 face value) for every Tata Motors share held.
IT major TCS reported Q2 net profit of ₹12,075 crore and revenue of ₹65,799 crore, with profits slightly beating estimates while revenues came in marginally below. EBIT stood at ₹16,565 crore, reflecting a margin of 25.2%, while constant currency revenue grew 0.8% QoQ.
TCS also outlined ambitious AI-led growth plans, including a 1 GW AI data center in India, the acquisition of ListEngage to strengthen Salesforce capabilities, and declared a second interim dividend of ₹11 per share.
Tata Elxsi delivered a Q2 net profit of ₹154.8 crore, marking a 7.2% QoQ increase from ₹144.4 crore. Revenue grew 2.9% QoQ to ₹918.1 crore, while EBIT climbed 4.7% to ₹169.9 crore. Operating margins improved to 18.5%, compared to 18.2% in the previous quarter, indicating steady operational efficiency.
NATCO Pharma achieved a significant legal breakthrough, paving the way to launch a generic version of Risdiplam, a treatment for Spinal Muscular Atrophy (SMA) — a rare and severe muscle disorder in infants. This landmark legal victory strengthens NATCO’s position in the high-value rare disease drug segment.
Shapoorji Pallonji Group’s Afcons Infrastructure secured a ₹576 crore contract for civil and allied infrastructure works. The project is expected to enhance the company’s order book and reinforce its position in the infrastructure development space.
ICICI Prudential Life reported new business premium of ₹1,761 crore, slightly lower than the expected ₹1,776 crore, but reflecting a 6.1% YoY increase. Annualised Premium Equivalent (APE) came in at ₹871 crore, higher than ₹722 crore last month but down 1.1% YoY, indicating stable but moderate growth momentum in its insurance business.
With developments ranging from AI investments by TCS, corporate restructuring at Tata Motors, legal victories in pharma, to infrastructure contracts and insurance premium growth, today’s trading session is expected to witness stock-specific action across diverse sectors.
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in the securities market are subject to market risks, read all the related documents carefully before investing.
Published on: Oct 10, 2025, 8:46 AM IST
Neha Dubey
Neha Dubey is a Content Analyst with 3 years of experience in financial journalism, having written for a leading newswire agency and multiple newspapers. At Angel One, she creates daily content on finance and the economy. Neha holds a degree in Economics and a Master’s in Journalism.
Know MoreWe're Live on WhatsApp! Join our channel for market insights & updates
Get the link to download the App
